Skip to main content

Table 4 Differences between subjects reporting GIT problems and those who did not report GIT symptoms following supplementation

From: Development of a complex amino acid supplement, Fatigue Reviva™, for oral ingestion: initial evaluations of product concept and impact on symptoms of sub-health in a group of males

 

Pre-supplementation

Post-supplementation

Measure

Subjects reporting GIT symptoms post-supplement (mean)

Subjects GIT symptom free post-supplement (mean)

Pvalue

Subjects reporting GIT symptoms post- supplement (mean)

Subjects GIT symptom free post-supplement (mean)

Pvalue

General health indices

      

 Neurological index

1.3

0.5

< 0.004

1.0

0.4

ns

Chalder fatigue scale

      

 Total fatigue scores

14.2

11.8

ns

12.6

8.9

ns

Amino acids

      

 (Relative % abundance)

 Asparagine

6.60%

4.78%

< 0.03

6.11%

4.89%

ns

 Hydroxylysine

1.62%

1.15%

< 0.05

1.72%

1.32%

ns

 Hydroxyproline

0.58%

0.34%

< 0.04

0.65%

0.52%

ns

  1. Statistical test: Mann–Whitney U. n = 5 and 12 for the participants reporting GIT symptoms and those who did not report GIT symptoms respectively. ns = statistically non-significant.